Catheter Precision's top three insider shareholders as of September 09, 2026 are David A Jenkins (Ex. Chairman Of The Board, 279.86K shares), Andrew C. Jackson (Cfo, 21.68K shares), James Joseph Caruso (Director, 50 shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David A Jenkins | Ex. Chairman Of The Board | 277,597 | 2,264 | 279,861 | 92.8% | 24 Mar, 2023 |
| 2 | Andrew C. Jackson | Cfo | 21,680 | 0 | 21,680 | 7.2% | 24 May, 2022 |
| 3 | James Joseph Caruso | Director | 50 | 0 | 50 | 0.0% | 08 Dec, 2025 |
| 4 | Jonathan Will Mcguire | Chief Executive Officer | 50 | 0 | 50 | 0.0% | 24 May, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 26 Mar, 2026 | Andrew Arno | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 26 Mar, 2026 | Martin J Colombatto | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 26 Mar, 2026 | Philip J Anderson | Chief Financial Officer | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 26 Mar, 2026 | James Joseph Caruso | Director | Acquired A | 40,000 | $0.00 | $0 | 40,000 | Direct |
| 05 Dec, 2025 | James Joseph Caruso | Director | Acquired C | 41 | $0.00 | $0 | 50 | Direct |
| 05 Dec, 2025 | James Joseph Caruso | Director | Disposed C | 8 | $0.00 | $0 | 0 | Direct |
| 12 Aug, 2025 | Andrew Arno | Director | Acquired A | 50,000 | $0.00 | $0 | 0 | Direct |
| 12 Aug, 2025 | Martin J Colombatto | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 12 Aug, 2025 | James Joseph Caruso | Director | Acquired A | 50,000 | $0.00 | $0 | 50,000 | Direct |
| 29 Jan, 2025 | Martin J Colombatto | Director | Disposed S | 3 | $0.40 | $1 | 0 | Indirect |
| 29 Jan, 2025 | Marie-Claude Jacques | Chief Commercial Officer | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 29 Jan, 2025 | James Joseph Caruso | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 29 Jan, 2025 | Andrew Arno | Director | Acquired A | 100,000 | $0.00 | $0 | 0 | Direct |
| 29 Jan, 2025 | Marie-Claude Jacques | Chief Commercial Officer | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 29 Jan, 2025 | Marie-Claude Jacques | Chief Commercial Officer | Acquired A | 125,000 | $0.00 | $0 | 125,000 | Direct |
| 29 Jan, 2025 | Martin J Colombatto | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 06 Jan, 2025 | Philip J Anderson | Chief Financial Officer | Acquired A | 500,000 | $0.00 | $0 | 500,000 | Direct |
| 01 May, 2024 | Marie-Claude Jacques | Chief Commercial Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 01 May, 2024 | Marie-Claude Jacques | Chief Commercial Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |
| 01 May, 2024 | Marie-Claude Jacques | Chief Commercial Officer | Acquired A | 250,000 | $0.00 | $0 | 250,000 | Direct |